LEADER 03652nam a2200853Ia 4500
001 10.1016-j.ijbiomac.2020.12.142
008 220427s2021 CNT 000 0 und d
020 |a 01418130 (ISSN) 
245 1 0 |a SARS-Cov-2 ORF3a: Mutability and function 
260 0 |b Elsevier B.V.  |c 2021 
856 |z View Fulltext in Publisher  |u https://doi.org/10.1016/j.ijbiomac.2020.12.142 
520 3 |a In this study, analysis of changes of SARS-CoV-2 ORF3a protein during pandemic is reported. ORF3a, a conserved coronavirus protein, is involved in virus replication and release. A set of 70,752 high-quality SARS-CoV-2 genomes available in GISAID databank at the end of August 2020 have been scanned. All ORF3a mutations in the virus genomes were grouped according to the collection date interval and over the entire data set. The considered intervals were: start of collection-February, March, April, May, June, July and August 2020. The top five most frequent variants were examined within each collection interval. Overall, seventeen variants have been isolated. Ten of the seventeen mutant sites occur within the transmembrane (TM) domain of ORF3a and are in contact with the central pore or side tunnels. The other variant sites are in different places of the ORF3a structure. Within the entire sample, the five most frequent mutations are V13L, Q57H, Q57H + A99V, G196V and G252V. The same analysis identified 28 sites identically conserved in all the genome isolates. These sites are possibly involved in stabilization of monomer, dimer, tetramerization and interaction with other cellular components. The results here reported can be helpful to understand virus biology and to design new therapeutic strategies. © 2020 Elsevier B.V. 
650 0 4 |a amino acid sequence 
650 0 4 |a Amino Acid Sequence 
650 0 4 |a Article 
650 0 4 |a chemistry 
650 0 4 |a conserved sequence 
650 0 4 |a Conserved Sequence 
650 0 4 |a Conserved sites 
650 0 4 |a controlled study 
650 0 4 |a COVID-19 
650 0 4 |a Databases, Genetic 
650 0 4 |a dimer 
650 0 4 |a epidemiology 
650 0 4 |a Evolution, Molecular 
650 0 4 |a genetic database 
650 0 4 |a genetics 
650 0 4 |a Genome, Viral 
650 0 4 |a GISAID databank 
650 0 4 |a human 
650 0 4 |a Humans 
650 0 4 |a Models, Molecular 
650 0 4 |a molecular evolution 
650 0 4 |a molecular model 
650 0 4 |a monomer 
650 0 4 |a Mutated sites 
650 0 4 |a mutation 
650 0 4 |a Mutation 
650 0 4 |a nonhuman 
650 0 4 |a ORF3a 
650 0 4 |a ORF3a protein 
650 0 4 |a ORF3a protein, SARS-CoV-2 
650 0 4 |a pandemic 
650 0 4 |a Pandemics 
650 0 4 |a physiology 
650 0 4 |a Pore 
650 0 4 |a protein domain 
650 0 4 |a protein function 
650 0 4 |a protein interaction 
650 0 4 |a protein quaternary structure 
650 0 4 |a protein stability 
650 0 4 |a protein structure 
650 0 4 |a Protein Structure, Quaternary 
650 0 4 |a proteome 
650 0 4 |a Proteome 
650 0 4 |a Q57H 
650 0 4 |a SARS-CoV-2 
650 0 4 |a SARS-CoV-2 
650 0 4 |a Severe acute respiratory syndrome coronavirus 2 
650 0 4 |a tetramer 
650 0 4 |a tetramerization 
650 0 4 |a time factor 
650 0 4 |a Time Factors 
650 0 4 |a unclassified drug 
650 0 4 |a viral protein 
650 0 4 |a virology 
650 0 4 |a Viroporin Proteins 
650 0 4 |a virus genome 
650 0 4 |a virus mutation 
700 1 |a Bianchi, M.  |e author 
700 1 |a Borsetti, A.  |e author 
700 1 |a Ciccozzi, M.  |e author 
700 1 |a Pascarella, S.  |e author 
773 |t International Journal of Biological Macromolecules